The Barack Obama administration's insistence that Iran discuss its ballistic missile programme in the negotiations for a comprehensive nuclear agreement brings its position into line with that of Israel and senators who introduced legislation drafted by the pro-Israel lobby group AIPAC aimed at torpedoing the negotiations.
Eight years ago, Stephen Rosen, then a top official at the American Israel Public Affairs Committee (AIPAC) and well-known around Washington for his aggressiveness, hawkish views, and political smarts, was asked by Jeffrey Goldberg of the New Yorker magazine whether some recent negative publicity had harmed the lobby group’s legendary clout in Washington.
In what looks to be a clear victory - at least for now - for President Barack Obama, a major effort by the Israel lobby and its most powerful constituent, the American Israel Public Affairs Committee (AIPAC), to pass a new sanctions bill against Iran has stalled in the U.S. Senate.
This week’s introduction by a bipartisan group of 26 senators of a new sanctions bill against Iran could result in the biggest test of the political clout of the Israel lobby here in decades.
Israeli and Palestinian negotiators returned to the negotiating table on Thursday, ready to put claims by the United States that it will engage more forcefully in the negotiating process to the test.
Like the proverbial skunk at the garden party, Israeli Prime Minister Benjamin Netanyahu used his turn at the podium at the U.N. General Assembly Tuesday to pour scorn on Iran’s new president, 96 hours after a smiling Hassan Rouhani departed New York after a momentous four-day stay that raised unprecedented hopes for détente with the United States and the West.
Just three weeks ago, Washington’s hawks, particularly of the pro-Israel neo-conservative variety, were flying high, suddenly filled with hope.
With Congress still deliberating over Barack Obama’s request for authorisation to take military action against Syria, the powerful Israel lobby here has taken the lead in pressing the president’s case.
In an important boost for President Barack Obama, two key Republicans and the Israel’s lobby’s two most influential groups Tuesday announced their support for a proposed Congressional resolution authorising limited military strikes against Syria for its alleged use of chemical weapons.
Israel and its domestic U.S. lobby are already in the early stages of the next 10-year aid package, which would not go into effect until 2017 and will be the first since Congress passed the Naval Vessel Transfer Act of 2008, which requires in part that U.S. military aid to Israel ensure that Israel maintains its "Qualitative Military Edge" (QME) over any combination of states and non-state actors.
For the first time in many months, supporters of intensified diplomatic engagement with Iran appear to be gaining strength here.
With President Barack Obama reportedly primed to nominate former Republican Sen. Chuck Hagel to head the Pentagon early next week, the powerful Israel lobby, led by the American Israel Public Affairs Committee (AIPAC), faces a major dilemma.
The media did their best to make the U.S. presidential election look important, the altar on which democracy is built. But there has been a problem ever since the Supreme Court legalised unlimited campaign spending (six billion dollars this year), thereby authorising one more freedom of expression, called "commercial speech" even though much of this speech is libellous, often neither true nor relevant.
The Democratic National Convention erupted in controversy this week over the removal of a clause in the party platform stating that Jerusalem should remain Israel’s undivided capital and only grew worse when the wording was hastily re-inserted.
Congress’s rush to pass new sanctions against Iran ahead of the August recess comes amidst an intensified drive to pin the Iranian government to deadly acts of international terrorism and amplified moves by U.S. politicians to demonstrate their support for Mideast ally Israel ahead of the November presidential election.